BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9406855)

  • 1. The full agonistic effect of recombinant 20 kDa human growth hormone (hGH) on CHO cells stably transfected with hGH receptor cDNA.
    Wada M; Ikeda M; Takahashi Y; Asada N; Chang KT; Takahashi M; Honjo M
    Mol Cell Endocrinol; 1997 Oct; 133(2):99-107. PubMed ID: 9406855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the effect on the human prolactin receptor.
    Tsunekawa B; Wada M; Ikeda M; Uchida H; Naito N; Honjo M
    Endocrinology; 1999 Sep; 140(9):3909-18. PubMed ID: 10465259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Large-scale preparation and in vitro characterization of biologically active human placental (20 and 22K) and pituitary (20K) growth hormones: placental growth hormones have no lactogenic activity in humans.
    Solomon G; Reicher S; Gussakovsky EE; Jomain JB; Gertler A
    Growth Horm IGF Res; 2006; 16(5-6):297-307. PubMed ID: 17010651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular activities of 20K- and 22K-hGH do not necessarily correlate with their binding affinities for rat GH receptor.
    Ikeda M; Matsumoto K; Uchida H; Naito N; Tsunekawa B; Wada M; Honjo M
    Horm Res; 2000; 54(3):136-42. PubMed ID: 11357007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding between the stem regions of human growth hormone (GH) receptor compensates for the weaker site 1 binding of 20-kDa human GH (hGH) than that of 22-kDa hGH.
    Tsunekawa B; Wada M; Ikeda M; Banba S; Kamachi H; Tanaka E; Honjo M
    J Biol Chem; 2000 May; 275(21):15652-6. PubMed ID: 10748003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 20-kilodalton (kDa) human growth hormone (hGH) differs from the 22-kDa hGH in the complex formation with cell surface hGH receptor and hGH-binding protein circulating in human plasma.
    Wada M; Uchida H; Ikeda M; Tsunekawa B; Naito N; Banba S; Tanaka E; Hashimoto Y; Honjo M
    Mol Endocrinol; 1998 Jan; 12(1):146-56. PubMed ID: 9440818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20 kDa human growth hormone (20K hGH) stimulates insulin-like growth factor-I (IGF-I) gene expression at lower concentrations than 22K hGH in hGH receptor-expressing Ba/F3 cells.
    Yoshizato H; Tanaka M; Fujikawa T; Higashimoto Y; Shimizu A; Nakashima K
    Endocr J; 2000 Mar; 47 Suppl():S37-40. PubMed ID: 10890180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A membrane-fixed, truncated isoform of the human growth hormone receptor.
    Amit T; Bergman T; Dastot F; Youdim MB; Amselem S; Hochberg Z
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3813-7. PubMed ID: 9360546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel bioassay based on human growth hormone (hGH) receptor mediated cell proliferation: measurement of 20K-hGH and its modified forms.
    Ikeda M; Wada M; Fujita Y; Takahashi S; Maekawa K; Honjo M
    Growth Horm IGF Res; 2000 Oct; 10(5):248-55. PubMed ID: 11042021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activities of synthesized 20K and 22K hGH in Nb2 bioassay and IM-9 radioreceptor assay.
    Ohmae Y; Yano H; Umezawa S; Tanaka T; Hibi I; Miyamoto C; Furuichi Y
    Endocrinol Jpn; 1989 Feb; 36(1):9-13. PubMed ID: 2731487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription.
    Goh EL; Pircher TJ; Wood TJ; Norstedt G; Graichen R; Lobie PE
    Endocrinology; 1997 Aug; 138(8):3207-15. PubMed ID: 9231769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GH induced lipolysis stimulation in 3T3-L1 adipocytes stably expressing hGHR: analysis on signaling pathway and activity of 20K hGH.
    Asada N; Takahashi Y; Wada M; Naito N; Uchida H; Ikeda M; Honjo M
    Mol Cell Endocrinol; 2000 Apr; 162(1-2):121-9. PubMed ID: 10854705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of binding properties between 20 kDa human growth hormone (hGH) and hGH receptor (hGHR): the binding affinity for hGHR extracellular domain and mode of receptor dimerization.
    Uchida H; Banba S; Wada M; Matsumoto K; Ikeda M; Naito N; Tanaka E; Honjo M
    J Mol Endocrinol; 1999 Dec; 23(3):347-53. PubMed ID: 10601980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear translocation and retention of growth hormone.
    Mertani HC; Raccurt M; Abbate A; Kindblom J; Törnell J; Billestrup N; Usson Y; Morel G; Lobie PE
    Endocrinology; 2003 Jul; 144(7):3182-95. PubMed ID: 12810575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding of growth hormone-binding protein is inhibited by hydroxamic acid-based protease inhibitors: proposed mechanism of activation of growth hormone-binding protein secretase.
    Amit T; Amit T; Hochberg Z; Yogev-Falach M; Youdim MB; Youdim MB; Barkey RJ
    J Endocrinol; 2001 May; 169(2):397-407. PubMed ID: 11312156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-induced internalization and phosphorylation-dependent degradation of growth hormone receptor in human IM-9 cells.
    Saito Y; Teshima R; Yamazaki T; Ikebuchi H; Sawada J
    Mol Cell Endocrinol; 1994 Dec; 106(1-2):67-74. PubMed ID: 7895916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 20kDa and 22kDa forms of human growth hormone (hGH) exhibit different intracellular signalling profiles and properties.
    Yao-Xia L; Jing-Yan C; Xia-Lian T; Ping C; Min Z
    Gen Comp Endocrinol; 2017 Jul; 248():49-54. PubMed ID: 28427901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning of a teleost growth hormone receptor and its functional interaction with human growth hormone.
    Lee LT; Nong G; Chan YH; Tse DL; Cheng CH
    Gene; 2001 May; 270(1-2):121-9. PubMed ID: 11404009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor binding properties of the 20K variant of human growth hormone explain its discrepant insulin-like and growth promoting activities.
    Smal J; Closset J; Hennen G; De Meyts P
    Biochem Biophys Res Commun; 1986 Jan; 134(1):159-65. PubMed ID: 3004426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant deoxyribonucleic acid-derived 22K- and 20K-human growth hormone generate equivalent diabetogenic effects during chronic infusion in dogs.
    Ader M; Agajanian T; Finegood DT; Bergman RN
    Endocrinology; 1987 Feb; 120(2):725-31. PubMed ID: 3542508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.